Skip to content
Maui Sky – Lifestyle
Author:
LB Pharmaceuticals Inc
LB Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 NOVA-2 Trial of LB-102 in Schizophrenia
July 22, 2026
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
July 10, 2026
LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations
June 30, 2026
LB Pharmaceuticals to Participate in Upcoming June Investor Events
May 28, 2026
LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 12, 2026
←
Previous Page
1
2